43 %In this study, the G1764A mutation in the BCP region was found in 18 out of 42 (43%) asymptomatic carriers.
Nigeriahépatite Bpublié 2025Viruseseurope_pmcdocument de 6 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
134 evidences · page 5 / 6
43 %In this study, the G1764A mutation in the BCP region was found in 18 out of 42 (43%) asymptomatic carriers.
Nigeriahépatite Bpublié 2025Viruseseurope_pmcdocument de 6 observations
2,7 %The prevalence of HBeAg among 150 PLHIV in the study was 2.7%.
Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations
The low frequency of individuals vaccinated against HBV suggests a need for improved vaccination services.
Nigeriahépatite Bpublié 2022Journal of immunoassay & immunochemistryPubMeddocument de 5 observations
8,3 %HBV was detected in 8.3% of 400 blood donors at the Federal Medical Center in Azare.
Nigeriahépatite Bpublié 2025BMC infectious diseasesPubMeddocument de 5 observations
18,7 %Twenty-eight (18.7%) of 150 PLHIV had at least one serological marker of hepatitis B virus.
Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations
16,1 %HBsAg prevalence among 310 HIV-positive individuals in Southwestern Nigeria was 16.1% (50/310).
Nigeriahépatite B · VIH/sidaobservé June 2017 to August 2017publié 2021Virology journalPubMeddocument de 6 observations
100 %Hepatitis B screening was performed in all 31 hospitals (100%).
Nigeriahépatite Bobservé 2014publié 2016International healtheurope_pmcdocument de 11 observations
6,9 %Hepatitis B surface antigen (HBsAg) prevalence was 6.9% among 248 patients at the Federal Medical Center, Makurdi.
Nigeriahépatite Bpublié 2024BMC public healthPubMeddocument de 7 observations
3,22 %Among HIV-positive patients aged 21–30 years in the study, the prevalence of HIV/HBV co-infection was 3.22%.
Nigeriahépatite B · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations
6,2 %The seroprevalence rate for hepatitis B virus among blood donors at the Lagos University Teaching Hospital in Nigeria was 6.2% over the 2015–2019 period.
Nigeriahépatite Bobservé 2015-2019publié 2022British journal of haematologyPubMeddocument de 7 observations
10,4 %The highest HBV prevalence in Nigeria was 10.4% in the north-central geopolitical zone.
Nigeriahépatite Bobservé 2018publié 2025Pathogens (Basel, Switzerland)PubMeddocument de 8 observations
11,8 %The proportion with HBV was 11.8% among those with tattoo/body incision.
Nigeriahépatite Bpublié 2022Journal of immunoassay & immunochemistryeurope_pmcdocument de 5 observations
15 %The frequency of HBeAg among HBV mono-infected cohort was 15%.
Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 11 observations
1,1 %The prevalence of HIV-hepatitis B-hepatitis C triple infection among people living with HIV/AIDS in a rural Northern Nigerian community was 1.1%.
Nigeriahépatite B · hépatite C · VIH/sidapublié 2020The Pan African medical journalPubMeddocument de 4 observations
14,8 %Among PLHIV aged 31–40 years, the prevalence of anti-HBs was 14.8%.
Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations
3,5 %The prevalence of hepatitis B surface antigenemia among HIV positive patients on anti-retroviral treatment programme in Anyigba, Kogi State, North-Central Nigeria was 3.5%.
Nigeriahépatite B · VIH/sidapublié 2019African health sciencesPubMed
7,3 %The proportion with HBV was 7.3% among those with history of sharing of sharp objects.
Nigeriahépatite Bpublié 2022Journal of immunoassay & immunochemistryeurope_pmcdocument de 5 observations
2,49 adjusted_odds_ratioThe absence of HBV vaccination was independently associated with HBV infection in pregnancy, with an adjusted odds ratio of 2.49.
Nigeriahépatite Bobservé November 1, 2017 to April 30, 2018publié 2020Annals of African medicinePubMeddocument de 5 observations
10,9 %Among 265 livestock handlers in Ibadan, Nigeria, 29 (10.9%) tested positive for HBV infection.
Nigeriahépatite Bobservé October 2016 to April 2017publié 2024African health sciencesPubMeddocument de 5 observations
33 %In this study, the A1762T mutation in the BCP region was found in 14 out of 42 (33%) asymptomatic carriers.
Nigeriahépatite Bpublié 2025Viruseseurope_pmcdocument de 6 observations
1,9 adjusted_odds_ratioHIV co-infection was independently associated with HBV infection in pregnancy, with an adjusted odds ratio of 1.90.
Nigeriahépatite B · VIH/sidaobservé November 1, 2017 to April 30, 2018publié 2020Annals of African medicinePubMeddocument de 5 observations
12,8 %The classical PC mutant variant G1899A was observed in 12.8% of sequenced BCP/PC gene amplicons.
Nigeriahépatite Bpublié 2023Viruseseurope_pmcdocument de 6 observationsDOI 10.3390/v15112188
49,9 unitless_ratioPWR for HBV negative participants was 49.9 ± 28.6, higher than that for HBV positive participants (41.4 ± 17.6).
Nigeriahépatite Bpublié 2021West African journal of medicineeurope_pmcdocument de 4 observations
6,1 %Among female PLHIV participants, the prevalence of anti-HBe was 6.1%.
Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations
0,4 %Among 265 livestock handlers in Ibadan, Nigeria, 1 (0.4%) was coinfected with HBV and HCV.
Nigeriahépatite B · hépatite Cobservé October 2016 to April 2017publié 2024African health sciencesPubMeddocument de 5 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.